Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gilead Sciences (GILD)
NASDAQ:GILD
Gilead Sciences (GILD) Stock Price & Analysis
11,957 Followers
GILD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$63.31 - $86.75
Previous Close$80.48
Volume6.78M
Average Volume (3M)5.52M
Market Cap
$100.28B
Enterprise Value$118.79B
Total Cash (Recent Filing)$6.67B
Total Debt (Recent Filing)$25.25B
Price to Earnings (P/E)18.5
Beta0.51
Next Earnings
Nov 07, 2023EPS Estimate
$1.92Last Dividend Ex-Date
Sep 14, 2023Dividend Yield
2.98 (3.74%)Share Statistics
EPS (TTM)4.35
Shares Outstanding1,246,014,353
10 Day Avg. Volume5,417,720
30 Day Avg. Volume5,524,480
Standard Deviation0.07
R-Squared0.08
Alpha0.00234
Financial Highlights & Ratios
Price to Book (P/B)-6.49
Price to Sales (P/S)15.28
Price to Cash Flow (P/CF)14.90
P/FCF Ratio14.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.35
Enterprise Value/Gross Profit5.49
Enterprise Value/Ebitda11.16
Forecast
1Y Price Target
$89.40Price Target Upside12.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Gilead Sciences News
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GILD FAQ
What was Gilead Sciences’s price range in the past 12 months?
Gilead Sciences lowest stock price was $63.31 and its highest was $86.75 in the past 12 months.
What is Gilead Sciences’s market cap?
Currently, no data Available
When is Gilead Sciences’s upcoming earnings report date?
Gilead Sciences’s upcoming earnings report date is Nov 07, 2023 which is in 19 days.
How were Gilead Sciences’s earnings last quarter?
Gilead Sciences released its earnings results on Aug 03, 2023. The company reported $1.34 earnings per share for the quarter, missing the consensus estimate of $1.642 by -$0.302.
Is Gilead Sciences overvalued?
According to Wall Street analysts Gilead Sciences’s price is currently Undervalued.
Does Gilead Sciences pay dividends?
Gilead Sciences pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 3.76%. See more information on Gilead Sciences dividends here
What is Gilead Sciences’s EPS estimate?
Gilead Sciences’s EPS estimate is $1.92.
How many shares outstanding does Gilead Sciences have?
Gilead Sciences has 1,246,014,400 shares outstanding.
What happened to Gilead Sciences’s price movement after its last earnings report?
Gilead Sciences reported an EPS of $1.34 in its last earnings report, missing expectations of $1.642. Following the earnings report the stock price went up 4.171%.
Which hedge fund is a major shareholder of Gilead Sciences?
Among the largest hedge funds holding Gilead Sciences’s share is Dodge & Cox. It holds Gilead Sciences’s shares valued at 3B.
---
Gilead Sciences Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.40 (12.21% Upside)
$89.40 (12.21% Upside)
Blogger Sentiment
Bullish
GILD Sentiment 88%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Very Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.82%
12-Months-Change
Fundamentals
Return on Equity
26.50%
Trailing 12-Months
Asset Growth
-0.85%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Gilead Sciences
Founded in 1987, California-based Gilead Sciences, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of antiviral drugs used in the treatment of diseases like human immunodeficiency virus (HIV), hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. It offers its products under brands including Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi.
---
Top 5 ETFs holding GILD
Global X S&P 500 Covered Call ETF
$7.47M
Zacks Earnings Consistent Portfolio ETF
$480.39K
ClearBridge Dividend Strategy ESG ETF
$291.96K
Global X S&P 500 Covered Call & Growth ETF
$160.58K
Global X S&P 500 ESG Covered Call ETF
$9.03K
Up to five ETFs with an Outperform Smart Score that hold GILD. The ETFs are listed according to market value of GILD within the ETF
---